ESPERVITA THERAPEUTICS Trademark

Trademark Overview

On Wednesday, February 13, 2019, a trademark application was filed for ESPERVITA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ESPERVITA THERAPEUTICS trademark a serial number of 88300521. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, March 14, 2023. This trademark is owned by Espervita Therapeutics, Inc.. The ESPERVITA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

A full line of medicated and pharmaceutical preparations, both prescription and over-the-counter, pertaining to metabolic disease and oncology
espervita therapeutics

General Information

Serial Number88300521
Word MarkESPERVITA THERAPEUTICS
Filing DateWednesday, February 13, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, March 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements

Goods and ServicesA full line of medicated and pharmaceutical preparations, both prescription and over-the-counter, pertaining to metabolic disease and oncology
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 7, 2019
Primary Code005
First Use Anywhere DateSunday, July 1, 2018
First Use In Commerce DateMonday, October 1, 2018

Trademark Owner History

Party NameEspervita Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSaline, MI 48176
Party NameEspervita Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaline, MI 48176

Trademark Events

Event DateEvent Description
Tuesday, March 14, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, March 14, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, March 14, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 31, 2022NON-FINAL ACTION E-MAILED
Wednesday, August 31, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, August 17, 2022STATEMENT OF USE PROCESSING COMPLETE
Saturday, August 13, 2022USE AMENDMENT FILED
Saturday, August 13, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, February 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 18, 2022SOU EXTENSION 5 GRANTED
Friday, February 11, 2022SOU EXTENSION 5 FILED
Friday, February 18, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 11, 2022SOU TEAS EXTENSION RECEIVED
Friday, August 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 11, 2021SOU EXTENSION 4 GRANTED
Wednesday, August 11, 2021SOU EXTENSION 4 FILED
Wednesday, August 11, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 12, 2021SOU EXTENSION 3 GRANTED
Friday, February 12, 2021SOU EXTENSION 3 FILED
Friday, February 12, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020SOU EXTENSION 2 GRANTED
Monday, August 10, 2020SOU EXTENSION 2 FILED
Monday, August 10, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 7, 2020SOU EXTENSION 1 GRANTED
Friday, February 7, 2020SOU EXTENSION 1 FILED
Friday, February 7, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 13, 2019ASSIGNED TO LIE
Thursday, April 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 25, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, April 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 25, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, April 25, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 24, 2019ASSIGNED TO EXAMINER
Thursday, March 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 16, 2019NEW APPLICATION ENTERED

Related Keywords

therapeutics espervita pertaining counter metabolic disease oncology over prescription medicated line pharmaceutical